Abstract
Breast cancer is the heterogeneous disease and leading cause of death in women, worldwide. It is generally caused by the perturbation of various signaling pathways responsible for cell apoptosis. Due to genetic variability, different signaling pathways are disrupted in different breast cancer patients; so, to overcome this multifaceted condition, the personalized treatment is preferred. Since, various potential targets exist in breast cancer cells; it raised the need of new prospective of lead compounds. A large number of evidences show that, due to the presence of various secondary metabolites in plants, natural compounds are frequently examined for search of new bioactive molecules. This review includes the pathological aspects of breast cancer and the effect of natural compounds on breast cancer cells along with their possible mechanism of action. (Databases searched were PubMed, Science Direct, Web of Knowledge, Scopus, and Google Scholar).
Keywords: Caspase, oncogenesis, apoptosis, prooxidants, arbutin, caffeolquinic acid, polyphenols.
Graphical Abstract
Anti-Cancer Agents in Medicinal Chemistry
Title:Natural Compounds A Weapon to Ameliorate Breast Cancer Cells: A Review
Volume: 17 Issue: 3
Author(s): Ruchi Singh Thakur and Bharti Ahirwar
Affiliation:
Keywords: Caspase, oncogenesis, apoptosis, prooxidants, arbutin, caffeolquinic acid, polyphenols.
Abstract: Breast cancer is the heterogeneous disease and leading cause of death in women, worldwide. It is generally caused by the perturbation of various signaling pathways responsible for cell apoptosis. Due to genetic variability, different signaling pathways are disrupted in different breast cancer patients; so, to overcome this multifaceted condition, the personalized treatment is preferred. Since, various potential targets exist in breast cancer cells; it raised the need of new prospective of lead compounds. A large number of evidences show that, due to the presence of various secondary metabolites in plants, natural compounds are frequently examined for search of new bioactive molecules. This review includes the pathological aspects of breast cancer and the effect of natural compounds on breast cancer cells along with their possible mechanism of action. (Databases searched were PubMed, Science Direct, Web of Knowledge, Scopus, and Google Scholar).
Export Options
About this article
Cite this article as:
Thakur Singh Ruchi and Ahirwar Bharti, Natural Compounds A Weapon to Ameliorate Breast Cancer Cells: A Review, Anti-Cancer Agents in Medicinal Chemistry 2017; 17 (3) . https://dx.doi.org/10.2174/1871520616666160826150659
DOI https://dx.doi.org/10.2174/1871520616666160826150659 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Delivery Systems for Brain Tumor Therapy
Current Pharmaceutical Design New Vessel Formation in the Central Nervous System During Tumor Growth, Vascular Malformations, and Moyamoya
Current Neurovascular Research MicroRNA Mediated Network and DNA Methylation in Colorectal Cancer
Protein & Peptide Letters Effects of Estrogens on Atherogenesis
Current Vascular Pharmacology Anti-inflammatory Lipid Mediators Derived from ω-6 and ω-3 Polyunsaturated Fatty Acids as a Treatment Option for IBD
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry 89Zr Radiochemistry for Positron Emission Tomography
Medicinal Chemistry COX-2 Inhibition in Esophagitis, Barretts Esophagus and Esophageal Cancer
Current Pharmaceutical Design Human Exposure to Endocrine Disruptors and Breast Milk
Endocrine, Metabolic & Immune Disorders - Drug Targets 99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents
Anti-Cancer Agents in Medicinal Chemistry Inhibition of NF-kB Activation and Cytokines Production in THP-1 Monocytes by 2-Styrylchromones
Medicinal Chemistry Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
Inflammation & Allergy - Drug Targets (Discontinued) MicroRNA and Cancer: Tiny Molecules with Major Implications
Current Genomics Role of Androgen Receptor in Prostate Cancer Cell Cycle Regulation: Interaction with Cell Cycle Regulatory Proteins and Enzymes of DNA Synthesis
Current Protein & Peptide Science Behcets Syndrome: Literature Review
Current Rheumatology Reviews Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine
Current Topics in Medicinal Chemistry Quantitative Structure-Activity Relationship Studies: Understanding the Mechanism of Tyrosine Kinase Inhibition
Current Enzyme Inhibition Functional and Molecular Ultrasound Imaging: Concepts and Contrast Agents
Current Medicinal Chemistry Proteasome Inhibitors: Recent Advances and New Perspectives In Medicinal Chemistry
Current Topics in Medicinal Chemistry Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Current Drug Targets